Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

SHE:002399 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	17,592	14,152	15,345	17,090	22,787	23,671
Market Cap Growth	38.70%	-7.78%	-10.21%	-25.00%	-3.74%	-2.72%
Enterprise Value	17,676	15,456	19,083	19,992	24,281	25,891
Last Close Price	13.13	10.47	11.49	12.47	16.56	16.52
PE Ratio	47.66	21.88	-	23.49	94.63	23.11
Forward PE	21.70	22.53	22.53	22.53	22.53	22.53
PS Ratio	3.36	2.69	2.83	2.39	3.58	4.44
PB Ratio	1.44	1.16	1.28	1.38	1.98	2.03
P/TBV Ratio	1.86	1.49	1.66	1.81	2.62	2.71
P/FCF Ratio	10.02	7.10	-	-	-	-
P/OCF Ratio	9.03	6.45	38.53	-	-	634.89
EV/Sales Ratio	3.37	2.94	3.51	2.79	3.82	4.86
EV/EBITDA Ratio	22.77	15.05	180.70	15.71	22.01	20.11
EV/EBIT Ratio	40.56	20.72	-	20.02	29.13	25.54
EV/FCF Ratio	10.07	7.75	-	-	-	-
Debt / Equity Ratio	0.25	0.29	0.46	0.52	0.49	0.48
Debt / EBITDA Ratio	3.37	3.33	38.64	4.95	4.98	4.28
Debt / FCF Ratio	1.76	1.78	-	-	-	-
Asset Turnover	0.29	0.29	0.27	0.36	0.33	0.31
Inventory Turnover	0.68	0.58	0.67	0.84	1.11	1.19
Quick Ratio	1.10	1.09	0.76	0.94	1.19	1.52
Current Ratio	2.29	2.60	2.13	2.22	2.25	2.53
Return on Equity (ROE)	3.14%	5.17%	-6.58%	5.97%	2.01%	10.66%
Return on Assets (ROA)	2.02%	2.55%	-0.68%	3.13%	2.73%	3.70%
Return on Capital (ROIC)	2.25%	2.80%	-0.75%	3.46%	3.02%	4.07%
Return on Capital Employed (ROCE)	4.40%	5.50%	-	6.60%	5.80%	6.60%
Earnings Yield	2.30%	4.57%	-5.10%	4.26%	1.06%	4.33%
FCF Yield	9.98%	14.09%	-0.26%	-5.73%	-0.88%	-0.74%
Dividend Yield	1.91%	2.39%	-	0.80%	0.21%	0.91%
Payout Ratio	-	-	-	34.51%	171.31%	43.69%
Buyback Yield / Dilution	-0.15%	0.54%	-0.67%	-0.05%	-8.42%	-8.51%
Total Shareholder Return	1.76%	2.93%	-0.67%	0.75%	-8.21%	-7.60%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.